Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $27.39B. Across the group, the median move over the past trading day is +0.48%. Price change over the past year runs from +21.9% to +79.8% across the middle 80 percent of the group, with a median of +36.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| 0KSX.L | Quest Diagnostics Incorporated | $243.72 | +0.48% | +42.44% | +36.94% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| 0JSY.L | Labcorp Holdings Inc. | $334.61 | +1.86% | +33.14% | +20.97% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.